67 related articles for article (PubMed ID: 20693795)
1. Proliferation activity is significantly elevated in partially embolized cerebral arteriovenous malformations.
Sandalcioglu IE; Asgari S; Wende D; van de Nes JA; Dumitru CA; Zhu Y; Gizewski ER; Stolke D; Sure U
Cerebrovasc Dis; 2010; 30(4):396-401. PubMed ID: 20693795
[TBL] [Abstract][Full Text] [Related]
2. Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells.
Jabbour MN; Elder JB; Samuelson CG; Khashabi S; Hofman FM; Giannotta SL; Liu CY
Neurosurgery; 2009 Jan; 64(1):139-46; discussion 146-8. PubMed ID: 19145162
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment increases but gamma knife radiosurgery decreases angiogenic activity of arteriovenous malformations: an in vivo experimental study using a rat cornea model.
Akakin A; Ozkan A; Akgun E; Koc DY; Konya D; Pamir MN; Kilic T
Neurosurgery; 2010 Jan; 66(1):121-9; discussion 129-30. PubMed ID: 20023542
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity through extracellular signal-regulated kinase of smooth muscle cells in vascular walls of cerebral arteriovenous malformations.
Takagi Y; Kikuta K; Sadamasa N; Nozaki K; Hashimoto N
Neurosurgery; 2006 Apr; 58(4):740-8; discussion 740-8. PubMed ID: 16575338
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor plasma levels are significantly elevated in patients with cerebral arteriovenous malformations.
Sandalcioglu IE; Wende D; Eggert A; Müller D; Roggenbuck U; Gasser T; Wiedemayer H; Stolke D
Cerebrovasc Dis; 2006; 21(3):154-8. PubMed ID: 16388189
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor κB in cerebral arteriovenous malformations.
Aziz MM; Takagi Y; Hashimoto N; Miyamoto S
Neurosurgery; 2010 Dec; 67(6):1669-79; discussion 1679-80. PubMed ID: 21107198
[TBL] [Abstract][Full Text] [Related]
7. Microvascular proliferation in congenital vascular malformations of skin and soft tissue.
Meijer-Jorna LB; van der Loos CM; de Boer OJ; van der Horst CM; van der Wal AC
J Clin Pathol; 2007 Jul; 60(7):798-803. PubMed ID: 16816171
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory molecule expression in cerebral arteriovenous malformations.
Storer KP; Tu J; Karunanayaka A; Morgan MK; Stoodley MA
J Clin Neurosci; 2008 Feb; 15(2):179-84. PubMed ID: 17997314
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic molecule expression in cerebral vascular malformations.
Storer KP; Tu J; Karunanayaka A; Morgan MK; Stoodley MA
J Clin Neurosci; 2007 Oct; 14(10):975-80. PubMed ID: 17646102
[TBL] [Abstract][Full Text] [Related]
10. Thrombus and encapsulated hematoma in cerebral cavernous malformations.
Abe M; Fukudome K; Sugita Y; Oishi T; Tabuchi K; Kawano T
Acta Neuropathol; 2005 May; 109(5):503-9. PubMed ID: 15759126
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic proteins in the lungs of children after cavopulmonary anastomosis.
Starnes SL; Duncan BW; Kneebone JM; Rosenthal GL; Patterson K; Fraga CH; Kilian KM; Mathur SK; Lupinetti FM
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):518-23. PubMed ID: 11547304
[TBL] [Abstract][Full Text] [Related]
12. [Radiosurgery for large cerebral arteriovenous malformations].
Nataf F; Merienne L; Schlienger M
Neurochirurgie; 2001 May; 47(2-3 Pt 2):298-303. PubMed ID: 11404708
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations.
Ng I; Tan WL; Ng PY; Lim J
J Clin Neurosci; 2005 Sep; 12(7):794-9. PubMed ID: 16165361
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations.
Sure U; Battenberg E; Dempfle A; Tirakotai W; Bien S; Bertalanffy H
Neurosurgery; 2004 Sep; 55(3):663-9; discussion 669-70. PubMed ID: 15335434
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and management of brain arteriovenous malformations in elderly patients.
Hashimoto H; Iida J; Kawaguchi S; Sakaki T
Acta Neurochir (Wien); 2004 Oct; 146(10):1091-8; discussion 1098. PubMed ID: 15316880
[TBL] [Abstract][Full Text] [Related]
16. Increased lengthening rate decreases expression of fibroblast growth factor 2, platelet-derived growth factor, vascular endothelial growth factor, and CD31 in a rat model of distraction osteogenesis.
Schiller JR; Moore DC; Ehrlich MG
J Pediatr Orthop; 2007 Dec; 27(8):961-8. PubMed ID: 18209624
[TBL] [Abstract][Full Text] [Related]
17. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
18. Expression of myosin heavy chain isoforms by smooth muscle cells in cerebral arteriovenous malformations.
Hoya K; Asai A; Sasaki T; Nagata K; Kimura K; Kirino T
Acta Neuropathol; 2003 May; 105(5):455-61. PubMed ID: 12677445
[TBL] [Abstract][Full Text] [Related]
19. [Toward an anatomoclinical classification for arteriovenous malformations?].
Nataf F; Meder JF
Neurochirurgie; 2001 May; 47(2-3 Pt 2):188-9. PubMed ID: 11404695
[TBL] [Abstract][Full Text] [Related]
20. Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: a histopathological follow-up.
Mazal PR; Stichenwirth M; Gruber A; Sulzbacher I; Hainfellner JA
Pathology; 2006 Feb; 38(1):28-32. PubMed ID: 16484004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
